MOTS-c Research Guide
MOTS-c Research Guide
MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded by mitochondrial DNA and studied for its role in AMPK activation, glucose metabolism, fat oxidation, and exercise-mimetic signalling pathways.
Quick Research Reference
REF- Full Name
- Mitochondrial ORF of the 12S rRNA Type-c
- Peptide Type
- Mitochondrial-derived peptide
- Encoding Source
- Mitochondrial DNA (12S rRNA region)
- Common Research Range
- 5–10 mg, 3–5× per week
- Administration Studied
- Subcutaneous
- Reconstitution
- 2–3mL bacteriostatic water per 10mg vial
- Storage After Reconstitution
- 2–8°C; return promptly after use
- Stability Note
- More sensitive than most research peptides
- Research Use Status
- Lab use only
MOTS-c — Mitochondrial ORF of the 12S rRNA Type-c — is a 16-amino acid peptide first identified in 2015. Unlike the vast majority of peptides studied in research, which are encoded by nuclear DNA, MOTS-c is encoded within the 12S rRNA region of mitochondrial DNA. This makes it one of a small and specialised class of compounds known as mitochondrial-derived peptides.
MOTS-c has attracted significant research interest because of its connection to AMPK, widely described as the body’s master metabolic switch. AMPK is activated by exercise, fasting, and periods of cellular energy stress. Because MOTS-c appears to engage similar downstream pathways, it is frequently studied as an exercise-mimetic peptide — a tool for understanding how mitochondria communicate metabolic signals to the rest of the cell.
Research into MOTS-c spans metabolic regulation, glucose metabolism, fat oxidation, insulin sensitivity, and age-related physical decline. Its discovery also helped reshape the understanding of mitochondria as active signalling organelles, not merely energy producers.
Peptide House supplies MOTS-c for laboratory and research use only.
A Peptide Encoded by Mitochondrial DNA
MOTS-c occupies a genuinely unusual position in peptide research. Its mitochondrial DNA origin sets it apart structurally and conceptually from almost every other compound in the research peptide field.
Mitochondrial-Derived Peptides: A New Research Class
MOTS-c belongs to a small group of compounds known as mitochondrial-derived peptides (MDPs). This class includes Humanin and SHLP1–6, which are also encoded by mitochondrial DNA. These peptides have helped establish that mitochondria serve a broader biological function than energy production alone.
What makes MOTS-c particularly notable within this class:
- Encoded within the 12S rRNA region of mitochondrial DNA — a non-coding region previously thought to have no peptide-encoding function
- Acts as a signalling peptide from mitochondria to the rest of the cell and potentially to distant tissues
- Has been shown to translocate to the nucleus under metabolic stress conditions, where it may influence nuclear gene expression
- Circulating MOTS-c levels increase with exercise and decline with age, linking it to both exercise biology and ageing research
- Engages the AMPK pathway through a mechanism involving folate-methionine metabolism and AICAR accumulation
The nuclear translocation of MOTS-c under metabolic stress is particularly significant because it suggests a direct communication role between mitochondrial DNA and the nuclear genome — a relatively new area of cellular biology research.
How MOTS-c Is Thought to Work
MOTS-c acts as a mitochondrial signalling peptide whose primary researched mechanism involves activation of AMPK through an indirect metabolic pathway. Rather than binding directly to a single receptor, MOTS-c appears to influence cellular metabolism upstream, leading to AMPK activation as a downstream result.
Mitochondrial Release
MOTS-c is produced within mitochondria and released into the cytoplasm. Under metabolic stress, it can also translocate to the nucleus, where it may influence nuclear gene expression — a unique characteristic among mitochondrial-derived peptides.
Folate-Methionine Cycle Disruption
MOTS-c is proposed to interfere with the folate-methionine metabolic cycle, a pathway involved in one-carbon metabolism. This disruption alters the availability of key metabolic intermediates within the cell.
AICAR Accumulation
The disruption of folate-methionine metabolism leads to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a naturally occurring metabolite that is a known activator of AMPK.
AMPK Activation
Accumulated AICAR activates AMPK, triggering a cascade of downstream metabolic effects including increased glucose uptake, enhanced fatty acid oxidation, improved insulin sensitivity, and support for mitochondrial biogenesis. These are the same pathways activated by exercise and fasting.
Downstream Metabolic Effects
AMPK activation drives the cellular metabolic responses studied in MOTS-c research: improved glucose tolerance, reduced fat storage signalling, increased energy expenditure, and metabolic flexibility. This is why MOTS-c is characterised as an exercise-mimetic compound in the research literature.
Research Applications
MOTS-c is studied across several interconnected areas of metabolic, mitochondrial, and ageing research. Its AMPK-activating mechanism positions it at the intersection of multiple active research fields.
Metabolic and Glucose Research
The primary research application for MOTS-c is studying its role in metabolic homeostasis and cellular energy regulation, particularly in relation to glucose metabolism and insulin sensitivity.
Research areas include:
- Glucose uptake and transport in skeletal muscle models
- Insulin sensitivity and insulin resistance research
- Metabolic flexibility and energy expenditure
- Fatty acid oxidation and lipid metabolism
- Obesity-related metabolic dysfunction models
- Glucose tolerance in animal research models
Preclinical research has associated MOTS-c administration with improved glucose tolerance and reduced metabolic dysfunction in animal models, making it a significant compound in metabolic disease research.
AMPK and Cellular Energy Research
MOTS-c is studied as a tool for investigating AMPK signalling in research settings where direct AMPK activation is the primary interest. Its indirect mechanism via AICAR accumulation makes it distinct from other AMPK research tools.
Research areas include:
- AMPK activation pathways and downstream signalling
- Mitochondrial biogenesis stimulation
- Cellular energy sensing and adaptation
- Folate-methionine cycle and one-carbon metabolism research
- AICAR-mediated signalling pathways
- Comparison of AMPK activation methods in metabolic research models
MOTS-c’s mechanism through folate-methionine disruption and AICAR accumulation provides researchers with a distinct mode of AMPK activation compared with direct AMPK activators or metformin-based research models.
Exercise-Mimetic and Performance Research
MOTS-c is one of the most discussed exercise-mimetic compounds in metabolic research because circulating MOTS-c levels rise with exercise and it activates the same downstream AMPK pathways as physical activity. This makes it valuable in studies where exercise capacity is limited, reduced, or being modelled.
Research areas include:
- Exercise-induced metabolic signalling models
- Skeletal muscle glucose uptake and energy regulation
- Exercise tolerance in models of metabolic impairment
- Mitochondrial communication with skeletal muscle
- Physical performance in aged animal models
- Whole-body energy balance responses to exercise-mimetic compounds
The finding that exercise itself increases circulating MOTS-c is particularly significant — it positions MOTS-c as both a downstream product of exercise biology and a potential upstream mediator of exercise-related metabolic benefits.
Ageing and Healthspan Research
MOTS-c levels appear to decline with age, and this decline has been associated with age-related metabolic dysfunction, reduced physical capacity, and mitochondrial deterioration. This makes MOTS-c an important compound in ageing and healthspan research.
Research areas include:
- Age-related decline in MOTS-c levels and metabolic function
- Mitochondrial dysfunction in ageing models
- Physical capacity and muscle performance in aged animal models
- Insulin resistance associated with ageing
- Healthspan and lifespan research in preclinical models
- Mitochondrial signalling changes across different age groups
The age-related decline in MOTS-c is an active area of research interest because it may help explain some of the metabolic and physical changes associated with normal ageing.
Mitochondrial Signalling Research
MOTS-c is a key research tool for understanding mitochondrial communication — how mitochondria signal to other parts of the cell and to distant tissues. Its nuclear translocation behaviour under metabolic stress is particularly significant for mito-nuclear communication research.
Research areas include:
- Mito-nuclear communication and retrograde signalling
- Nuclear translocation of mitochondrial-derived peptides under stress
- Mitochondrial ORF biology and the 12S rRNA region
- Mitochondrial-derived peptide class research (Humanin, SHLP peptides, MOTS-c)
- Mitochondrial stress response and adaptive signalling
- Gene expression changes downstream of MOTS-c nuclear activity
MOTS-c’s ability to translocate to the nucleus and influence nuclear gene expression is a relatively newly described phenomenon that has significant implications for understanding how mitochondrial and nuclear genomes coordinate under metabolic stress.
Technical Specifications
| Specification | Details |
|---|---|
| Name | MOTS-c |
| Full Name | Mitochondrial ORF of the 12S rRNA Type-c |
| Other Names | Mitochondrial-Derived Peptide, MDP, Exercise Mimetic Peptide |
| Encoding Source | Mitochondrial DNA (12S rRNA region) |
| Peptide Type | Mitochondrial-derived peptide |
| Amino Acid Count | 16 |
| Sequence | MRWQEMGYIFYPRKLR |
| Molecular Formula | C₁₀₁H₁₅₂N₂₈O₂₂S₂ |
| Molecular Weight | 2174.68 g/mol |
| CAS Number | 1627580-64-6 |
| Isoelectric Point | Approx. 10.5 |
| Net Charge at pH 7 | Approx. +4 |
| Appearance | White to off-white lyophilised powder |
| Solubility | Soluble in water and aqueous buffers |
| Stability | More sensitive to degradation than most research peptides |
| Storage, Lyophilised | 2–8°C short term; -20°C long term |
| Storage, Reconstituted | 2–8°C; return to refrigeration promptly |
| Intended Use | Laboratory research use only |
Reconstitution Information
MOTS-c is supplied as a lyophilised powder and is commonly reconstituted with bacteriostatic water for research use. Because MOTS-c is more sensitive to degradation than most research peptides, careful handling and prompt cold storage are especially important.
General Laboratory Handling Considerations
Common reconstitution handling steps in laboratory settings include:
- Allowing the vial and bacteriostatic water to reach room temperature before handling — but minimising total time out of refrigeration
- Adding 2–3mL of bacteriostatic water slowly down the inside wall of the vial
- Not shaking the vial — allowing the powder to dissolve naturally or with gentle swirling
- Using sterile equipment and aseptic technique throughout
- Returning the reconstituted solution to refrigeration immediately after preparation
- Discarding the solution if it becomes cloudy, discoloured, or contains visible particles
Example Concentration Reference
| Vial Size | Water Added | Concentration | 5mg Research Volume | 10mg Research Volume |
|---|---|---|---|---|
| 10mg | 2mL | 5mg/mL | 1mL | 2mL |
| 10mg | 3mL | 3.33mg/mL | 1.5mL | 3mL |
For accuracy, use a peptide reconstitution calculator and ensure all measurements match the intended laboratory protocol. Due to MOTS-c’s relative instability, prepare only the volume required for immediate research use where practical.
Storage Guidelines
MOTS-c requires more careful storage attention than most research peptides due to its relative instability. Cold-chain handling should be maintained throughout all laboratory procedures.
Lyophilised Powder
Before reconstitution, MOTS-c should be stored sealed and protected from heat, light, and moisture. Minimise time at room temperature.
- Short-term: refrigerated at 2–8°C
- Long-term: frozen at approximately -20°C
- Keep sealed until ready for reconstitution
- Protect from direct light and humidity
- Avoid repeated temperature changes before opening
- Minimise room-temperature exposure during handling
Reconstituted Solution
After reconstitution, MOTS-c should be refrigerated immediately and returned to cold storage promptly after each use.
- Refrigerate at 2–8°C immediately after reconstitution
- Do not freeze after reconstitution
- Return to refrigeration promptly — do not leave at room temperature
- Use sterile technique each time the vial is accessed
- Avoid repeated warming and cooling of the solution
- Discard if cloudy, discoloured, or if particles are visible
Frequently Asked Questions
What makes MOTS-c different from other research peptides?
MOTS-c is encoded by mitochondrial DNA rather than nuclear DNA, placing it in a rare class of compounds known as mitochondrial-derived peptides (MDPs). Most peptides studied in research are products of nuclear genes. MOTS-c’s mitochondrial origin, its nuclear translocation behaviour under metabolic stress, and its role as a signalling molecule between mitochondria and other cellular compartments make it structurally and functionally unique in the peptide research field.
What is AMPK and why is it central to MOTS-c research?
AMPK (AMP-activated protein kinase) is an enzyme that acts as a key sensor of cellular energy status. When energy is low — during exercise, fasting, or metabolic stress — AMPK is activated and triggers pathways that restore energy balance: increased glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and improved insulin sensitivity. MOTS-c is studied because it appears to activate AMPK indirectly through folate-methionine cycle disruption and AICAR accumulation, engaging the same downstream pathways as exercise without requiring physical activity.
What is AICAR and what role does it play in MOTS-c’s mechanism?
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) is a naturally occurring metabolite and a known activator of AMPK. In the proposed MOTS-c mechanism, disruption of the folate-methionine metabolic cycle leads to an accumulation of AICAR within the cell. This AICAR accumulation then activates AMPK, triggering downstream metabolic effects. AICAR is itself a well-studied research compound in metabolism and exercise biology.
Why does MOTS-c decline with age and why does this matter for research?
Research has shown that circulating MOTS-c levels decrease with age, a pattern associated with the broader decline in mitochondrial function and signalling that accompanies ageing. Because MOTS-c supports metabolic regulation, glucose tolerance, and AMPK-mediated energy pathways, its age-related decline may contribute to the metabolic dysfunction, insulin resistance, and physical performance reduction commonly observed with ageing. This makes MOTS-c a key compound in studies of somatopause, metabolic ageing, and healthspan research.
How does MOTS-c relate to exercise biology?
Exercise has been shown to increase circulating MOTS-c levels, suggesting that MOTS-c may be one of the molecular signals through which exercise exerts its metabolic benefits. This finding positions MOTS-c as both a downstream product of exercise and a potential mediator of exercise-induced metabolic improvements — including improved insulin sensitivity, increased fat oxidation, and enhanced glucose uptake. This is the basis for its description as an exercise-mimetic peptide in the research literature.
What is nuclear translocation and why is it significant for MOTS-c research?
Nuclear translocation refers to the movement of a molecule from the cytoplasm into the cell nucleus. Under metabolic stress, MOTS-c has been observed to translocate to the nucleus, where it may directly influence nuclear gene expression. This is significant because it suggests a direct communication pathway between mitochondrial DNA and the nuclear genome — a relatively newly characterised form of mito-nuclear crosstalk that has broad implications for understanding cellular stress responses and adaptation.
Why is MOTS-c considered less stable than other research peptides?
MOTS-c contains methionine and tryptophan residues — amino acids that are particularly susceptible to oxidation — and its overall structure degrades more readily at room temperature compared with many other synthetic peptides. This makes cold-chain handling throughout all laboratory procedures especially important. Reconstituted MOTS-c should be returned to refrigeration immediately after use, and researchers should avoid prolonged room-temperature exposure at any stage of handling.
Can MOTS-c be studied alongside other metabolic research peptides?
MOTS-c is sometimes studied alongside other mitochondrial-derived peptides such as Humanin, or alongside metabolic compounds relevant to AMPK signalling. Because MOTS-c acts at a different level of the metabolic signalling cascade than GHRH analogues or GH secretagogues, it is generally studied in a distinct research context — metabolic regulation, mitochondrial biology, and exercise adaptation — rather than in GH-axis research models. Any combination research design should be determined by qualified researchers with appropriate ethical oversight.
Is MOTS-c approved for therapeutic or human use?
No. MOTS-c is not approved by the Therapeutic Goods Administration (TGA) or any other regulatory body for therapeutic or human use. Peptide House supplies MOTS-c strictly for laboratory and research purposes only. It is not a medicine, is not intended for human or animal consumption, and should be handled exclusively within an appropriate research or laboratory setting.
Peptide House Quality Standard
At Peptide House, quality, transparency, and consistency are central to our research peptide range. MOTS-c presents specific quality considerations that researchers should be aware of: its relative instability and sensitivity to oxidation mean that manufacturing, storage, and handling standards have a direct impact on research-grade integrity.
Because MOTS-c contains oxidation-sensitive residues and degrades more readily than many other research peptides, the quality of the starting material and the cold-chain conditions from synthesis to delivery are especially important.
Quality concerns specific to MOTS-c in the research peptide market may include:
- Oxidised methionine or tryptophan residues from poor handling or storage
- Lower-than-stated purity due to degradation before supply
- Incorrect peptide sequence or incomplete synthesis
- Inadequate cold-chain handling during shipping or storage
- Inaccurate peptide content or fill weight in the supplied vial
- Certificates of analysis lacking oxidation screening or mass spectrometry confirmation
Peptide House aims to provide researchers with clear product documentation, careful storage practices, and research peptides supplied with appropriate quality verification at the batch level.
What Researchers Should Look For
When assessing MOTS-c quality from any supplier, key indicators include:
- HPLC purity data confirming the 16-amino acid sequence is intact and unoxidised
- Mass spectrometry confirmation of molecular weight (2174.68 g/mol)
- Batch-specific certificates of analysis
- Evidence of appropriate cold-chain storage and shipping conditions
- Clear storage and handling guidance specific to MOTS-c’s stability profile
- Transparent product labelling and supply chain information
Shop MOTS-c at Peptide House
Peptide House supplies MOTS-c for laboratory and research use only.
| Product | Size | Price |
|---|---|---|
| MOTS-c | 10mg vial | [Insert price] |
View product details, storage information, and available documentation on the Peptide House product page.
References
Key studies commonly cited in MOTS-c research include:
- Lee C, et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell Metabolism, 2015.
- Reynolds JC, et al. “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.” Nature Communications, 2021.
- Lee C, et al. “MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism.” Free Radical Biology and Medicine, 2016.
- Kim SJ, et al. “Mitochondria-derived peptides in aging and healthspan.” Journal of Clinical Investigation, 2017.
- Zhai D, et al. “MOTS-c peptide increases survival and decreases bacterial load in mice infected with ESKAPE pathogens.” Vaccine, 2017.
- Kim KH, et al. “Mitochondrial peptides are multifunctional modulators of metabolic function.” Nature Reviews Endocrinology, 2017.
- Ramanjaneya M, et al. “Mitochondrial-derived peptides are down regulated in diabetes subjects.” Frontiers in Endocrinology, 2019.
- Cobb LJ, et al. “Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers.” Communications Biology, 2016.
- Lee C, et al. “MOTS-c: a mitochondrial-derived peptide for metabolic homeostasis and exercise-associated benefits.” Ageing Research Reviews, 2021.
- Bhatt DL, et al. “Mitochondrial-derived peptides and their emerging roles in metabolic disease research.” Trends in Endocrinology and Metabolism, 2022.